Folasaga
Liposomal NMN pautao lo'o vave ona suitulaga i le NMN masani i fa'aputuga fa'aopoopo fa'apitoa ona o le maualuga maualuga o le bioavailability ma sili atu le maualuga ole NAD⁺.
Mo tagata fa'atau B2B, fai konekarate, ma nutraceutical brands, o le suiga agai i le liposomal delivery e le o se aga-o se fa'ai'uga fa'atino-fa'avae i luga o le fa'aoga lelei, fa'atamaoaiga o mea tau tupe, ma -tulaga umi o oloa.
Standard NMN, e tusa lava po o le a le mama, e feagai ma le tele o pa puipui olaola e faʻatapulaʻaina lona aoga. Liposomal NMN, i se fa'afeagai, e fa'aogaina le fa'apalapala o le phospholipid e puipui ai le mole, fa'aalo muamua-fa'asolo le metabolism, ma fa'aleleia ai le feavea'i feavea'i.
Mea'ai Avea'ese (Fa'apitoa Snippet Optimization)
- Liposomal NMN o lo'o fa'aalia le maualuga maualuga ole NAD⁺ fa'atusatusa ile NMN masani ile fua tutusa
- Phospholipid encapsulation puipuia le NMN mai le faʻaleagaina ma faʻaleleia le faʻaogaina
- Liposomal tilivaina e le'i pasia muamua-le metabolism o le ate e ala ile lymphatic felauaiga
- Fa'aitiitiga fa'aoga lelei e fa'aitiitia ai le tau-i-fa'atinoga i fa'atutu
- Fa'ataga le fa'atulagaina o oloa fa'apitoa ile -fa'atauva'a ma maketi umi
O le a le Liposomal NMN Powder ma aisea e taua ai
Liposomal NMN pauta ose isi-augatupulaga NAD⁺ mea'ai muamua ua fuafuaina e fa'ato'ilaloina tapula'a o le NMN masani.
E le pei o le NMN paʻu masani, lea e faʻaalia i le gastric acid ma le enzymatic degradation, o le liposomal NMN o loʻo faʻapipiʻiina i totonu o le phospholipid bilayers e faʻataʻitaʻia ai sela o le tagata.
Mo tagata fa'atonu ma 'au fa'atau, o lona uiga:
- E sili atu ona iloa le mitiia
- Tuuina atu intracellular maualuga
Sili atu le fetaui ma le aoga-tulaga o oloa
Ole mea lea e fetaui lelei ai le liposomal NMN mo:
- Mea fa'aopoopo e -anti matua
- O mea tau eletise
- Fuafuaga umi umi
Ole Bioavailability Gap - Aisea e le lelei ai le Standard NMN
O le paʻu masani o le NMN e feagai ma ni pa puipui tetele se tolu:
1. Gastric Acid Degradation
Ole si'osi'omaga o le manava oona (pH 1.5-3.5) e mafai ona fa'aleagaina le NMN a'o le'i fa'aaogā.
2. Intestinal Enzymatic Breakdown
Fufulu ia enzymes tuaoi ma gut microbiota faaliliu le NMN i isi mea faʻapipiʻi aʻo leʻi faʻaaogaina.
3. Uluai -Pass Liver Metabolism
O le NMN faʻafefe e fealuaʻi i totonu o le vein portal i le ate, lea e vave faʻafefeteina i le nicotinamide (NAM), faʻaitiitia ai le maua o le tino.
O le i'uga, e na'o se vaega o le NMN fa'aogaina e saofagā i le fa'atupuina o le NAD⁺ i totonu o ga'o.
Fa'afefea ona Fa'aleleia e Liposomal NMN le fa'aulu ma le fa'ao'oina
Liposomal NMN o lo'o fa'aogaina le phospholipid-fa'avae le faiga e fa'atatau i nei tapula'a.
Mechanisms Autu:
1. Puipuiga Molecular
O le lipid bilayer e puipuia le NMN mai le faʻaleagaina o le acid ma le enzymatic.
2. Lymphatic Absorption Auala
Liposome e mitiia e ala i sela intestinal ma felauaiga i le lymphatic system, e ala i le metabolism o le ate.
3. Fa'asa'o Fa'asa'o Tele
O liposome e fusia ma sela sela, tuʻuina saʻo le NMN i totonu o le cytoplasm.
O lenei masini e mafua ai:
- Fa'atosina fa'asoasoa
- Sili atu NAD⁺ fa'aliliuga lelei
- Fa'ato'aga fa'aolaola taunu'uga
Fa'amatalaga Fa'afoma'i - E sili atu le aoga o le Liposomal NMN?
Ole su'esu'ega fa'alua-tauaso, placebo-e maua ai fa'amaoniga malosi mo le liposomal NMN fa'atinoga.
Vaaiga Aoaoga:
- Tagata auai: 15 alii (40+)
- Umi: 4 vaiaso
- Fuafuaga: 350 mg/aso
I'uga:
- Liposomal NMN vaega: +84% NAD⁺ faateleina
- E maualuga atu nai lo tulaga masani NMN ma placebo
- Fa'aauau le maualuga ole NAD⁺ e o'o ile 4 vaiaso talu ona fa'agata
O lo'o fa'ailoa mai ai o le liposomal NMN e le gata ina fa'aleleia atili le miti ae fa'apea fo'i -a'afiaga feavea'i umi.
Tau ma Fa'atinoga - A B2B Sourcing Va'aiga
| metric | Tulaga NMN | Liposomal NMN |
|---|---|---|
| Bioavailability | Maualalo– feololo | Maualuga |
| NAD⁺ Maualuga | Maulalo | Tulaga maualuga |
| Tulaga Manaomia | Maualuga | Maulalo |
| Tau o Mea Mata | Maulalo | Maualuga |
| Tau ile fua aoga | Maualuga | Maulalo pe tutusa |
| Tulaga Fa'apitoa | Fa'atapula'a | Malosi |
Malamalamaaga Autu:
E ui o le liposomal NMN e maualuga atu le tau o le iunite, e faʻaitiitia ai:
- Totogi mana'omia
- Fa'atapula'a le lapopo'a o capsule
- Tulaga lamatia o le le ogatasi o faatinoga
Ole mea lea e sili atu ai le tau-fa'aoga lelei ile-tulaga maualuga.
Fa'atonuga Fa'atonu mo NMN Ingredients
O le tulaga fa'atonutonu mo le NMN ua matua'i fa'atupula'ia.
- Ua faʻamaonia e le FDA le NMN e mafai ona maketiina e avea o se faʻaopoopoga meaʻai (2025 update)
- NMN ua fa'avasegaina o aMea'ai Fou (NDI)
- E mana'omia le tu'uina atu o le NDIN se'i vagana ua fa'amauina e faila o iai
Mo tagata fa'atau:
- E tatau ona aofia ai le filifiliga a le tagata fa'atau oloa:
- NDIN fa'amaumauga
- Vaega -fa'apitoa COA
- Fa'amaumauga o le su'esu'eina ma le tausisia
Fua'iga o Maketi - Le mafua'aga o le Liposomal NMN o lo'o tupu vave ai
- Ole maketi ole NMN ole lalolagi o loʻo fuafua e maua le tuputupu aʻe CAGR malosi
- Faʻateleina le manaʻoga mobioavailability-mea fa'alelei
- O lo'o agai atu tagata fa'ataufa'aopoopo -fa'asaienisi
Tulaga Autu:
"Tekinolosi tilivaina" ua avea ma se'ese'ese muamua-
e le na'o le mama o elemene.

Fa'afefea ona Filifili se Liposomal NMN Fa'atuatuaina Fa'atau
Pe a suʻeina le liposomal NMN paʻu, faʻamuamua:
- Mama e Sili atu pe tutusa ile 98% (HPLC)
- Fa'amatalaga lelei o le encapsulation
- Lapo'a (e masani lava 50–200 nm)
- Fa'amaumauga mautu (12-24 masina)
- Tusipasi (cGMP, ISO, Kosher, Halal)
Fa'ai'uga - E aoga le Liposomal NMN?
Mo tagata fa'atau B2B, o le liposomal NMN e le na'o le fa'aleleia atili-o se fofo e fa'atino-
Faʻatusatusa i le NMN masani, e ofoina atu:
- Fa'aolaola maualuga
- Fa'atosina sili atu ona lelei
- Malosi atu o le eseesega o oloa
A'o fa'atuputeleina le maketi fa'aopoopo umi, o mea e lagolagoina e tekinolosi fa'ao'o ma fa'amaoniaga fa'ama'i o le a fa'amalamalamaina le tulaga fa'atauva'a.
Laasaga e sosoo ai mo lau Fa'atulagaina
O le tele o tagata fa'atau e amata i se pailate vaega e fa'amaonia ai le fa'asalalauina, mautu, ma le fa'aliliuga lelei i totonu o latou matrix fa'apitoa a'o le'i fa'asolo ile gaosiga fa'apisinisi. O lo'o avanoa le COA fa'apitoa, fa'amaumauga mautu, ma le fa'atulagaina o ta'iala e lagolago ai lau fa'agasologa o le atina'eina o oloa.
- Talosaga mo fa'ata'ita'iga mo su'ega fa'asusu
- Avanoa i fa'amaumauga fa'atekinisi atoa (COA, mautu, lapopo'a)
- Fa'apitoa fa'amatalaga mo lau laina oloa
- Maua le lagolago mai le matou vaega R&D
- MOQ, taʻitaʻi taimi, ma le tele o tau e maua i luga ole talosaga.
Fa'afeso'ota'i la matou 'au fa'ainisinia ileliu@wellgreenxa.com.
Fa'asinomaga
- Ata 3: Auala Fa'atonu a le NMN ma Fa'agaioiina Metabolic.PMC, 2024.
- Ua faailoa mai e le FDA le Nicotinamide Mononucleotide o se mea'ai faaopoopo. (2025).Venable LLP.
- NMN Health Supplement Market e ala ile Form, Source Type, Distribution Channel, Application, End User - Global Forecast 2026-2032.360iSu'esu'ega, 2026.
- NAD Precursor Supplements Maketi.Malamalamaga Maketi i le Lumanai, 2025.
- US Anti-Atua'i Fa'aopoopo Fa'aopoopo Maketi Tele, Fa'asoa, & Fa'asologa o Su'esu'ega Lipoti e ala i mea'ai (Collagen, Resveratrol, NMN, Vitamini), E ala i le Fa'aogaina, E ala i le Fa'atulagaina, E ala i Fa'asoa Fa'asoa, Ma Va'aiga Va'aiga, 2025 – 2030.Suesuega ma Maketi.



